Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mikkelsen, A. L.
Right arrow Articles by Lindenberg, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mikkelsen, A. L.
Right arrow Articles by Lindenberg, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 16, No. 8, 1714-1718, August 2001
© 2001 European Society of Human Reproduction and Embryology

Morphology of in-vitro matured oocytes: impact on fertility potential and embryo quality

Anne Lis Mikkelsen2,1 and Svend Lindenberg,1

The Fertility Clinic Herlev University Hospital, Fruebjergvej 3, DK-2100 Copenhagen, Denmark

BACKGROUND: The purpose of the present study was to investigate the morphology of in-vitro matured metaphase II (MII) oocytes and to observe if there was a difference in the morphology between polycystic and normal ovaries. Furthermore, the morphology of in-vitro matured MII oocytes was related to their subsequent fertilization and cleavage rates and to embryo quality. METHODS: This retrospective study included 264 MII oocytes obtained in 100 consecutive cycles. Oocyte retrieval was performed transvaginally and cumulus enclosed oocytes were matured for 28–30 h before evaluation. Prior to ICSI, all MII oocytes were graded into three groups according to the number of anomalies: grade I: oocytes without any anomaly (n = 144, 54%), grade II: oocytes with one anomaly (n = 87, 33%) and grade III: oocytes with at least two anomalies (n = 33, 12.5%). RESULTS: Oocyte grades did not differ between women with polycystic ovaries [grades I, II and III respectively: 58/94 (61.7%), 29/94 (30.9%) and 7/94 (7.4%)] and women with normal ovaries [grades I, II and III respectively: 86/170 (50.6%); 58/170 (34%); 26/170 (15.3%)]. Morphology was not related to fertilization rates. The cleavage rate was, however, affected by morphological anomalies (grade I [77/144 (53.5%) versus grade II 33/87 (37.9%) (P = 0.03)], although no significant decrease in cleavage rate could be demonstrated when all grade II and III oocytes were compared with normal oocytes. Significantly more embryos of good quality developed after grade I oocytes [54/144 (37.5%)] compared with those from grade II and grade III oocytes (22/120; P = 0.001). The presence of cytoplasmic abnormalities significantly decreased the cleavage rate (P = 0.04) and also the number of good quality embryos (P < 0.001). CONCLUSION: The in-vitro maturation of oocytes without anomalies yields higher quality embryos, with higher cleavage rates, than those with anomalies.

Key words: embryo quality/fertilization/in-vitro maturation/oocyte morphology

1 To whom correspondence should be addressed. E-mail: alm{at}ciconia.dk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
S. Franks, J. Stark, and K. Hardy
Follicle dynamics and anovulation in polycystic ovary syndrome
Hum. Reprod. Update, May 22, 2008; (2008) dmn015v1.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Palomba, T. Russo, A. Falbo, F. Orio Jr, F. Manguso, E. Nelaj, A. Tolino, A. Colao, B. Dale, and F. Zullo
Clinical use of the perifollicular vascularity assessment in IVF cycles: a pilot study
Hum. Reprod., April 1, 2006; 21(4): 1055 - 1061.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
D. Nogueira, R. Ron-El, S. Friedler, M. Schachter, A. Raziel, R. Cortvrindt, and J. Smitz
Meiotic Arrest In Vitro by Phosphodiesterase 3-Inhibitor Enhances Maturation Capacity of Human Oocytes and Allows Subsequent Embryonic Development
Biol Reprod, January 1, 2006; 74(1): 177 - 184.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Revel, A. Safran, A. Benshushan, A. Shushan, N. Laufer, and A. Simon
In vitro maturation and fertilization of oocytes from an intact ovary of a surgically treated patient with endometrial carcinoma: Case report
Hum. Reprod., July 1, 2004; 19(7): 1608 - 1611.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Ebner, M. Moser, M. Sommergruber, M. Puchner, R. Wiesinger, and G. Tews
Developmental competence of oocytes showing increased cytoplasmic viscosity
Hum. Reprod., June 1, 2003; 18(6): 1294 - 1298.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Ebner, M. Moser, M. Sommergruber, C. Yaman, U. Pfleger, and G. Tews
First polar body morphology and blastocyst formation rate in ICSI patients
Hum. Reprod., September 1, 2002; 17(9): 2415 - 2418.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. T.Y. Chiu, M. S. Rogers, E. L.K. Law, C. M. Briton-Jones, L.P. Cheung, and C. J. Haines
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality
Hum. Reprod., June 1, 2002; 17(6): 1591 - 1596.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.